PCD Franchise for Ofloxacin 0.3% w/v & Dexamethasone 0.1% w/v Eye Drops – OXAONE-D by A1 Cure
PCD Franchise for Ofloxacin & Dexamethasone Eye Drops | OXAONE-D | A1 Cure
PCD Franchise for Ofloxacin 0.3% w/v & Dexamethasone 0.1% w/v Eye Drops:- The ophthalmic pharmaceutical sector is one of the fastest-growing segments in the healthcare industry. Increasing cases of bacterial eye infections, eye allergies, inflammation, and post-surgical eye care requirements have significantly boosted the demand for combination eye drop formulations. Among the most commonly prescribed ophthalmic medicines is Ofloxacin 0.3% w/v & Dexamethasone 0.1% w/v Eye Drops, a powerful combination used for managing bacterial eye infections accompanied by inflammation.
To cater to this growing demand, A1 Cure (Division of Life Pharma Distributor) offers an excellent PCD Pharma Franchise for OXAONE-D, a premium ophthalmic formulation trusted for quality, effectiveness, and business growth opportunities.
📱 Call/WhatsApp: +91 9878911111
🌐 Website: www.lifepharma.in
📧 Email: sales@lifepharma.in
Introduction to OXAONE-D Eye Drops
OXAONE-D Eye Drops combines a broad-spectrum antibacterial agent with an anti-inflammatory corticosteroid, making it a preferred choice for ophthalmic healthcare professionals.
Composition
Each ml contains:
- Ofloxacin IP 0.3% w/v
- Dexamethasone Sodium Phosphate equivalent to Dexamethasone 0.1% w/v
- Sterile ophthalmic base q.s.
This dual-action formulation helps address bacterial eye infections while supporting the reduction of inflammation and discomfort.
Key Benefits of OXAONE-D Eye Drops
The combination formulation offers multiple therapeutic advantages.
Major Benefits
✔ Broad-spectrum antibacterial support
✔ Helps manage bacterial eye infections
✔ Supports reduction of inflammation and redness
✔ Helps relieve eye discomfort and irritation
✔ Suitable for post-operative ophthalmic care under medical supervision
✔ Convenient ophthalmic dosage form
✔ High demand among ophthalmologists and eye care specialists
Therapeutic Applications
Healthcare professionals may prescribe OXAONE-D for:
- Bacterial Conjunctivitis
- Inflammatory Eye Conditions
- Post-Operative Eye Care
- Eye Redness Associated with Infection
- Bacterial Ocular Infections
- Eye Swelling and Irritation
- Secondary Eye Infections
Note: This medication should be used only under the supervision of a qualified healthcare professional.
Growing Demand for Ophthalmic Products in India
The ophthalmology market continues to expand rapidly due to several factors.
Increasing Eye Infections
Pollution, dust exposure, and changing environmental conditions have increased the prevalence of eye infections.
Digital Lifestyle
Extended screen exposure contributes to eye strain, dryness, and irritation, increasing the need for ophthalmic care.
Expanding Eye Care Infrastructure
The number of eye hospitals, specialty clinics, and vision centers is growing throughout India.
Greater Awareness About Eye Health
People are becoming increasingly aware of the importance of timely eye treatment and preventive care.
Why Invest in a PCD Franchise for OXAONE-D?
The ophthalmic segment offers tremendous growth opportunities for pharmaceutical entrepreneurs.
Consistent Market Demand
Eye infections and inflammatory conditions affect people of all age groups.
Regular Prescriptions
Ophthalmologists frequently prescribe antibiotic-steroid combinations for appropriate cases.
Excellent Business Potential
The eye care sector continues to grow across urban and rural markets.
Attractive Profit Margins
Franchise partners can benefit from competitive pricing and strong returns.
Repeat Business Opportunities
Eye care products generate regular demand through healthcare channels.
Why Choose A1 Cure?
A1 Cure has established itself as a trusted pharmaceutical company by providing quality products and comprehensive franchise support.
Franchise Advantages
✔ Monopoly Rights Availability
✔ Quality-Assured Ophthalmic Products
✔ Competitive Pricing Structure
✔ Wide Product Portfolio
✔ Timely Delivery System
✔ Attractive Promotional Inputs
✔ Professional Business Support
✔ Long-Term Growth Opportunities
Marketing Support Provided by A1 Cure
A1 Cure helps franchise partners build a strong market presence through:
- Visual Aids
- Product Literature
- Reminder Cards
- MR Bags
- Product Samples
- Visiting Cards
- Promotional Inputs
- Digital Marketing Assistance
Therefore, franchise associates receive the tools needed to expand their business efficiently.
Who Can Apply for the Franchise?
This opportunity is suitable for:
- Pharma Distributors
- Medical Representatives
- Stockists
- Wholesalers
- Retail Pharmacy Owners
- Healthcare Entrepreneurs
- Existing PCD Franchise Holders
Documents Required
Applicants generally require:
- Drug License
- GST Registration
- PAN Card
- Aadhaar Card
- Business Address Proof
How to Start a Franchise with A1 Cure?
Starting your franchise business is simple:
Step 1
Contact A1 Cure.
Step 2
Discuss territory and product requirements.
Step 3
Submit necessary business documents.
Step 4
Confirm monopoly rights availability.
Step 5
Place your first order and begin operations.
Future Scope of Ophthalmic Franchise Business
India’s eye care industry is expected to grow steadily in the coming years. Rising healthcare awareness, technological advancements, and improved access to ophthalmic treatments are creating new business opportunities. Consequently, products like OXAONE-D Eye Drops can play an important role in building a successful ophthalmic franchise business.
Why OXAONE-D Is a Smart Addition to Your Franchise Portfolio
The combination of Ofloxacin and Dexamethasone remains one of the most prescribed ophthalmic categories in clinical practice. Since bacterial eye infections often involve inflammation, healthcare professionals frequently rely on combination formulations that address both concerns. As a result, OXAONE-D offers strong market potential and consistent demand.
Conclusion
The ophthalmic market in India continues to present excellent opportunities for pharmaceutical distributors and entrepreneurs. OXAONE-D Eye Drops, containing Ofloxacin 0.3% w/v & Dexamethasone 0.1% w/v, represent a valuable product category with growing demand across healthcare settings.
By partnering with A1 Cure, franchise associates gain access to quality products, monopoly rights, promotional support, and long-term business opportunities.
📱 Call/WhatsApp: +91 9878911111
🌐 Website: www.lifepharma.in
📧 Email: sales@lifepharma.in
Frequently Asked Questions (FAQs)
1. What is OXAONE-D Eye Drops?
OXAONE-D is an ophthalmic formulation containing Ofloxacin 0.3% w/v and Dexamethasone 0.1% w/v.
2. What is the role of Ofloxacin in OXAONE-D?
Ofloxacin is a broad-spectrum antibacterial agent commonly used in ophthalmic formulations.
3. What is the role of Dexamethasone in OXAONE-D?
Dexamethasone is a corticosteroid that helps manage inflammation under medical supervision.
4. What conditions may OXAONE-D be prescribed for?
Healthcare professionals may prescribe it for bacterial eye infections associated with inflammation.
5. Who can apply for the A1 Cure PCD Franchise?
Distributors, wholesalers, stockists, MRs, and healthcare entrepreneurs can apply.
6. Does A1 Cure offer monopoly rights?
Yes, monopoly rights are available depending on territory availability.
7. What promotional support does A1 Cure provide?
A1 Cure provides visual aids, product literature, reminder cards, samples, and marketing materials.
8. Is the ophthalmic segment profitable?
Yes, ophthalmic products have strong demand and significant growth potential in India.
9. What documents are required for a franchise?
Drug License, GST Registration, PAN Card, Aadhaar Card, and address proof are generally required.
10. How can I start a franchise for OXAONE-D?
Simply contact A1 Cure, submit the required documents, discuss your territory, and begin your franchise business.
Related posts
September 12, 2026
September 12, 2026
September 12, 2026
